An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Worries
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Removal
According to the social media company, the service has removed violative content and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.
Within minutes of joining one group, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Details and Pricing
Within these groups, posts display dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.
